MAC News

MAC Clinical Research is proud to have partnered with Gilgamesh Pharma in the successful completion of a Phase 2a clinical

By Dr Shoona Vincent, Vice President of Clinical Science at MAC Clinical Research The psychedelic research renaissance is well underway,

The latest update from the MHRA and UK Government shows continued momentum in UK clinical research, with rising trial numbers

Selecting a Contract Research Organisation (CRO) is one of the most important decisions a Sponsor will make in the planning

As the year comes to a close, it’s a good time to pause and look back on everything we’ve achieved

MAC Clinical Research is proud to support Initiator Pharma as the full-service CRO partner for their upcoming Phase 2a clinical

We are proud to announce the successful completion of Kariya Pharmaceuticals’ Phase I clinical trial for KP405, a brain-penetrant GLP-1/GIP

The UK’s clinical research environment is changing, and quickly. Recent updates from the Medicines and Healthcare products Regulatory Agency (MHRA)

Contract Research Organisations (CROs) are often associated with the operational side of clinical trials: patient recruitment, data management, site monitoring

We are pleased to share that the first patient has now been dosed in a Phase 2 clinical trial –